Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	SNYSanofi SA	GSKGSK plc	BMYBristol Myers Squibb
Snapshot
Price	$45.40	$52.43	$66.31
Market cap	$98.73B	$102.51B	$118.71B
Valuation
P/E	7.4x	13.8x	23.3x
Forward P/E	5.3x	9.8x	18.4x
Growth
Revenue growth	43.7%	4.0%	1.8%
EPS growth	96.2%	86.7%	26.3%
Profitability
Net margin	17.2%	17.8%	12.3%
ROE	17.0%	35.8%	41.6%
Balance sheet & cash
Debt / equity	0.28x	1.08x	2.44x
Free cash flow yield	21.4%	3.8%	15.4%
Dividend yield	5.4%	3.5%	4.5%
Verdict
Investment rating	Strong· 80	Favorable· 66	Favorable· 60

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	SNYtoday $45	GSKtoday $52	BMYtoday $66
2027	$66.81 – $97.98+116% CAGR	$73.43 – $107.69+105% CAGR	$62.80 – $92.10+39% CAGR
2028	$131.07 – $192.24+106% CAGR	$137.11 – $201.09+96% CAGR	$79.29 – $116.30+32% CAGR
2029	$257.17 – $377.18+103% CAGR	$256.03 – $375.50+93% CAGR	$100.12 – $146.85+30% CAGR
2030	$504.56 – $740.02+101% CAGR	$478.08 – $701.18+91% CAGR	$126.43 – $185.43+29% CAGR
2031	$989.95 – $1,451.92+100% CAGR	$892.71 – $1,309.31+90% CAGR	$159.64 – $234.14+29% CAGR
5-yr CAGR	85.2% – 100.0%	76.3% – 90.3%	19.2% – 28.7%